Rein Therapeutics, Inc. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
Rein Therapeutics, Inc. (RNTX) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of 0.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2026-03-26
- Rein Therapeutics, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2025 was 0.20%.
- Rein Therapeutics, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2024 was 0.00%.
- Rein Therapeutics, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was -2.40%.
- Rein Therapeutics, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2022 was -0.90%.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month |
|---|---|
| 2025-12-31 | 0.20% 10-K · filed 2026-03-26 |
| 2024-12-31 | 0.00% 10-K · filed 2026-03-26 |
| 2023-12-31 | -2.40% 10-K · filed 2025-04-07 |
| 2022-12-31 | -0.90% 10-K · filed 2024-04-15 |
| 2021-12-31 | -0.50% 10-K · filed 2023-03-20 |
| 2020-12-31 | -0.60% 10-K · filed 2022-03-28 |
| 2019-12-31 | -0.60% 10-K · filed 2021-03-24 |
| 2018-12-31 | -0.90% 10-K · filed 2020-03-30 |
| 2017-12-31 | -2.10% 10-K · filed 2019-03-29 |
| 2016-12-31 | -1.30% 10-K · filed 2018-04-02 |
| 2015-12-31 | -1.60% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |